A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab-Reference-Cited by-同舟云学术

A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab

Published:2019-03-27 Issue:1 Volume:17 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Botticelli Andrea,Salati Massimiliano,Di Pietro Francesca Romana,Strigari Lidia,Cerbelli Bruna,Zizzari Ilaria Grazia,Giusti Raffaele,Mazzotta Marco,Mazzuca Federica,Roberto Michela,Vici Patrizia,Pizzuti Laura,Nuti Marianna,Marchetti Paolo

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-019-1847-x.pdf

Reference24 articles.

1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492 Epub 2018 Sep 12.

2. Planchard D, Popat S, Kerr K, et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Supplement_4):iv192–237. https://doi.org/10.1093/annonc/mdy275 .

3. Raju S, Joseph R, Sehgal S. Review of checkpoint immunotherapy for the management of non-small cell lung cancer. Immunotargets Ther. 2018;31(7):63–75. https://doi.org/10.2147/ITT.S125070 (eCollection 2018. Review).

4. Salati M, Baldessari C, Cerbelli B, et al. Nivolumab in pretreated non-small cell lung cancer: continuing the immunolution. Transl Lung Cancer Res. 2018;7(Suppl 2):S91–4. https://doi.org/10.21037/tlcr.2018.01.14 .

5. Reck M, Rodriguez-Abreu D, Robinson AG, et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med. 2016;375:1823–33.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centers;BMC Medicine;2024-09-11

2. Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review);International Journal of Oncology;2024-02-13

3. External validation of a nomogram predicting conditional survival after tri-modality treatment of esophageal cancer;Surgery;2023-12

4. Construction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China;BMC Cancer;2023-12-01

5. Novel nomogram for predicting survival in advanced non-small cell lung cancer receiving anti-PD-1 plus chemotherapy with or without antiangiogenic therapy;Frontiers in Immunology;2023-11-08